Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.39M | -10.08M | -13.65M | -10.43M | -13.96M |
| Total Depreciation and Amortization | 315.00K | 222.00K | 120.00K | 331.00K | 246.00K |
| Total Amortization of Deferred Charges | 26.00K | 129.00K | 146.00K | -85.00K | 14.00K |
| Total Other Non-Cash Items | 4.41M | 4.26M | 4.87M | 4.78M | 5.66M |
| Change in Net Operating Assets | 465.00K | 258.00K | -1.58M | -1.68M | -128.00K |
| Cash from Operations | -3.18M | -5.21M | -10.10M | -7.08M | -8.16M |
| Capital Expenditure | -8.00K | -1.00K | -9.00K | -13.00K | -89.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 8.80M |
| Cash from Investing | -8.00K | -1.00K | -9.00K | -13.00K | 8.71M |
| Total Debt Issued | 0.00 | 0.00 | 38.79M | -- | -- |
| Total Debt Repaid | 1.00K | -53.00K | -37.00M | -51.00K | -1.00K |
| Issuance of Common Stock | 207.00K | 0.00 | 241.00K | 106.00K | 205.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -47.00K | -460.00K | -- | 0.00 | -23.00K |
| Cash from Financing | 161.00K | -513.00K | 2.03M | 55.00K | 181.00K |
| Foreign Exchange rate Adjustments | -125.00K | 1.00K | -100.00K | 241.00K | 355.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.16M | -5.73M | -8.18M | -6.80M | 1.09M |